Mohamad Adham Salkeni, MD, FRCPC, discusses the mechanism of action of ivaltinostat and what rationalizes its use in combination with capecitabine for patients with metastatic pancreatic adenocarcinoma.
Mohamad Adham Salkeni, MD, FRCPC
Articles by Mohamad Adham Salkeni, MD, FRCPC